Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02838966 · ClinicalTrials.gov registry record · NA
Preoperative Nutrition With Immune Enhancing Nutritional Supplement (Immunomodulation)
A NA study, sponsored by University of Louisville.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT02838966: Clinical Trial NA study, sponsored by University of Louisville.
NCT02838966 is a NA study that was terminated before completion, run by University of Louisville. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02838966, a NA study, was terminated before completion, sponsored by University of Louisville.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the optimal effective dose for preoperative nutritional supplementation with immunomodulators on immune function and perioperative outcomes following pancreaticoduodenectomy for pancreatic adenocarcinoma.
Primary Outcome
The variable that will be compared in this analysis will be • Change in circulating Myeloid derived suppressor cells before and after intervention (before intervention: within 2 weeks before surgery; after intervention: day of surgery)
Interventions
- DIETARY_SUPPLEMENT Nestle IMPACT Advanced Recovery
- DIETARY_SUPPLEMENT Nestle Boost High Protein Drink
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2014-08 |
| Est. Completion | 2019-11-11 |
| Phase | NA |
Why NCT02838966 stopped before completion
NCT02838966 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Nestle IMPACT Advanced Recovery is the first listed.
NCT02838966 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02838966 about?
NCT02838966 is a clinical study titled "Preoperative Nutrition With Immune Enhancing Nutritional Supplement (Immunomodulation)". The purpose of this study is to determine the optimal effective dose for preoperative nutritional supplementation with immunomodulators on immune function and perioperative outcomes following pancreaticoduodenectomy for pancreatic adenocarcinoma.
What is the current status of trial NCT02838966?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2014-08. Estimated completion is 2019-11-11.
What interventions are being tested in trial NCT02838966?
The interventions under investigation include: Nestle IMPACT Advanced Recovery (DIETARY_SUPPLEMENT), Nestle Boost High Protein Drink (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02838966?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02838966's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia